Related Experiment Video

Updated: Jul 2, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial

C M McKinnon1, K A Lygoe, L Skelton

  • 1Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, UK.

Oncogene
|September 3, 2008
PubMed

Insights

Loss of RhoBTB2, a protein implicated in cancer, leads to decreased levels of the chemokine CXCL14. This finding clarifies a mechanism by which cancer cells may lose CXCL14 expression, impacting cell migration and angiogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • The Rho family of small GTPases are critical regulators of cell migration, invasion, and cell cycle, processes often dysregulated in cancer.
  • RhoBTB2/DBC2, an atypical Rho GTPase, exhibits altered expression in various cancers, but its functional role in tumorigenesis remains largely unknown.
  • CXCL14, a chemokine involved in leukocyte migration and angiogenesis, is frequently downregulated in epithelial cancers through poorly understood mechanisms.

Purpose of the Study:

  • To investigate the functional consequences of RhoBTB2 loss in primary human epithelial cells, mimicking its silencing in cancer.
  • To identify downstream targets of RhoBTB2 and elucidate the mechanisms behind CXCL14 downregulation in epithelial cancers.

Main Methods:

  • RNA interference (RNAi) was employed in primary human epithelial cells to deplete RhoBTB2 expression.
  • Microarray analysis was performed to assess global gene expression changes following RhoBTB2 loss.
  • CXCL14 secretion levels were measured in head and neck squamous cell carcinoma cell lines with varying RhoBTB2 expression.

Main Results:

  • Loss of RhoBTB2 expression resulted in the significant downregulation of CXCL14 gene expression.
  • RhoBTB2 depletion correlated with reduced CXCL14 secretion in head and neck squamous cell carcinoma cell lines.
  • Reintroduction of RhoBTB2 into cells restored CXCL14 secretion, confirming RhoBTB2's role in its regulation.

Conclusions:

  • This study identifies CXCL14 as a direct gene target of RhoBTB2.
  • Downregulation of CXCL14 is a functional consequence of RhoBTB2 loss in cancer.
  • The RhoBTB2-CXCL14 axis represents a novel pathway contributing to cancer progression and warrants further investigation.

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 406:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...